Cargando…
Strategic priorities for respiratory syncytial virus (RSV) vaccine development
Although RSV has been a high priority for vaccine development, efforts to develop a safe and effective vaccine have yet to lead to a licensed product. Clinical and epidemiologic features of RSV disease suggest there are at least 4 distinct target populations for vaccines, the RSV naïve young infant,...
Autores principales: | Anderson, L.J., Dormitzer, P.R., Nokes, D.J., Rappuoli, R., Roca, A., Graham, B.S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3919153/ https://www.ncbi.nlm.nih.gov/pubmed/23598484 http://dx.doi.org/10.1016/j.vaccine.2012.11.106 |
Ejemplares similares
-
Respiratory Syncytial Virus (RSV) Update
por: Krilov, Leonard R., et al.
Publicado: (2022) -
Reducing respiratory syncytial virus (RSV) hospitalization in a lower-income country by vaccinating mothers-to-be and their households
por: Brand, Samuel PC, et al.
Publicado: (2020) -
Respiratory Syncytial Virus (RSV)
por: Walsh, Edward E., et al.
Publicado: (2015) -
Pathobiology of Respiratory Syncytial Virus (RSV)
por: Tripp, Ralph A., et al.
Publicado: (2020) -
Modeling household dynamics on Respiratory Syncytial Virus (RSV)
por: Mahikul, Wiriya, et al.
Publicado: (2019)